Daidone MG - Search Results

1

3H-thymidine-labeling index as a prognostic indicator in node-positive breast cancer.

Silvestrini R, Daidone MG, Valagussa P, Di Fronzo G, Mezzanotte G, Mariani L, Bonadonna G. Silvestrini R, et al. Among authors: daidone mg. J Clin Oncol. 1990 Aug;8(8):1321-6. doi: 10.1200/JCO.1990.8.8.1321. J Clin Oncol. 1990. PMID: 2380758

2

Short-term tissue culture of human breast cancer: presence of estrogen receptors and 17 beta-estradiol stimulation of RNA synthesis.

Sanfilippo O, Daidone MG, Di Fronzo G, Silvestrini R. Sanfilippo O, et al. Among authors: daidone mg. Cancer. 1979 Jun;43(6):2365-9. doi: 10.1002/1097-0142(197906)43:6<2365::aid-cncr2820430629>3.0.co;2-u. Cancer. 1979. PMID: 455226

3

Relationship between proliferative activity and estrogen receptors in breast cancer.

Silverstrini R, Daidone MG, Di Fronzo G. Silverstrini R, et al. Among authors: daidone mg. Cancer. 1979 Aug;44(2):665-70. doi: 10.1002/1097-0142(197908)44:2<665::aid-cncr2820440237>3.0.co;2-n. Cancer. 1979. PMID: 476575

4

Prognostic significance of the labeling index in non-Hodgkin human malignant lymphomas.

Silvestrini R, Costa A, Daidone MG, Rilke F. Silvestrini R, et al. Among authors: daidone mg. Antibiot Chemother (1971). 1978;24:105-11. doi: 10.1159/000401506. Antibiot Chemother (1971). 1978. PMID: 655673

5

Biological characterisation of primary and metachronous lesions in breast cancer patients.

Silvestrini R, Valentinis B, Daidone MG, Di Fronzo G, Coradini D, Salvadori B. Silvestrini R, et al. Among authors: daidone mg. Eur J Cancer. 1992;28A(12):2006-10. doi: 10.1016/0959-8049(92)90249-2. Eur J Cancer. 1992. PMID: 1419299

6

Potentials of cell kinetics in the management of patients with ovarian cancers.

Silvestrini R, Daidone MG, Valentinis B, Ferraris C, Di Re E, Raspagliesi F, Landoni F, Scarfone G, Bolis G. Silvestrini R, et al. Among authors: daidone mg. Eur J Cancer. 1992;28(2-3):386-90. doi: 10.1016/s0959-8049(05)80059-0. Eur J Cancer. 1992. PMID: 1591051

7

Adjuvant CMF for node-negative and estrogen receptor-negative breast cancer patients.

Zambetti M, Bonadonna G, Valagussa P, Daidone MG, Coradini D, Bignami P, Contesso G, Silvestrini R. Zambetti M, et al. Among authors: daidone mg. J Natl Cancer Inst Monogr. 1992;(11):77-83. J Natl Cancer Inst Monogr. 1992. PMID: 1627434 Clinical Trial.

8

Laminin receptors, collagenase IV and prognosis in node-negative breast cancers.

Daidone MG, Silvestrini R, D'Errico A, Di Fronzo G, Benini E, Mancini AM, Garbisa S, Liotta LA, Grigioni WF. Daidone MG, et al. Int J Cancer. 1991 Jun 19;48(4):529-32. doi: 10.1002/ijc.2910480409. Int J Cancer. 1991. PMID: 1646175

9

Comparing core needle to surgical biopsies in breast cancer for cell kinetic and ploidy studies.

Daidone MG, Orefice S, Mastore M, Santoro G, Salvadori B, Silvestrini R. Daidone MG, et al. Breast Cancer Res Treat. 1991 Sep;19(1):33-7. doi: 10.1007/BF01975202. Breast Cancer Res Treat. 1991. PMID: 1756265

10

3H-thymidine labeling index, hormone receptors, and ploidy in breast cancers from elderly patients.

Valentinis B, Silvestrini R, Daidone MG, Coradini D, Galante E, Cerrotta AM, Abolafio G, Arboit L. Valentinis B, et al. Among authors: daidone mg. Breast Cancer Res Treat. 1991 Dec;20(1):19-24. doi: 10.1007/BF01833353. Breast Cancer Res Treat. 1991. PMID: 1813066

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

292 results

Search Page

Filters